Moderna handling content may be adapted by superintendent pharmacists for use in community pharmacy.

Read first

Resources underpinning pharmaceutical processes in PCNs for all vaccines
COVID-19 vaccines have different handling and dosing requirements. Sites need to plan to reduce the risk of errors where multiple vaccines are available.

Standard Operating Procedures

Each SOP and a summary of all major changes is provided.

Ordering COVID-19 Vaccine Moderna for PCN designated sites

Change history
  1. · Updated to refer to pull model
  2. · Page content remains accurate
  3. · Page content remains accurate
  4. · Page content remains accurate
  5. · Published

Receiving and storing COVID-19 Vaccine Moderna at PCN designated Sites

Change history
  1. · Section 4.2 addition to clarify wholesaler responsibility regarding transit time greater than 6 hours to delivery
  2. · Current content remains accurate
  3. · Current content still accurate
  4. · The name of the vaccine has changed to Spikevax®
  5. · Reworked to reflect the fact that PCNs will receive thawed Moderna COVID-19 vaccine
    1. · Published

Extending the post thaw expiry of Moderna (Spikevax) COVID-19 vaccine in PCN designated sites

Change history
  1. · Extension of the post thaw expiry of Spikevax® COVID-19 vaccine is no longer supported by Moderna
  2. · Content reviewed and accurate
  3. · First Published
  4. · Published

Preparing COVID-19 Vaccine Moderna at PCN Designated Sites

Change history
  1. · Current content remains accurate
  2. · Current content remains accurate
  3. · MVH 3b Section 7 corrected supporting dose work instruction reference to MVH 3.1b
  4. · MVH 3 renamed MVH 3a and updated to highlight this procedure is specific to the 0.5ml primary course dose. Added check that correct dose is being prepared and further advice to reduce risk of coring.
  5. · MVH 3.1 renamed MVH 3.1a and updated to highlight this instruction is specific to the 0.5ml primary course dose. Added check that correct dose is being prepared and further advice to reduce risk of coring.
    1. · MVH 3.2 updated to include both primary course and booster dose information
    2. · MVH 3b and MVH 3.1b uploaded as new documents specific to the 0.25ml booster dose
    3. · MVH3 Section 5.4.2 removal of outdated Foundry codes
    4. · MVH 3 3.1 and 3,2 the name of the vaccine has changed to Spikevax®
    5. · MVH3 Section 5.2.3 Amended reference to storage up to 25 degrees C to reflect extended time of 24 hours
    6. · MVH3 Section 5.3.1 amended to allow 11 doses to be withdrawn from each vial
    7. · MVH3.1 renumbered
    8. · Published

Stocktaking and reconciliation of COVID-19 Vaccine Moderna at PCN designated sites

Change history
  1. · Current content remains accurate
  2. · Current content remains accurate
  3. · Current content remains accurate
  4. · Section 4.3 removal of outdated Foundry codes
  5. · The name of the vaccine has changed to Spikevax®
    1. · Published

Disposing of damaged, unused or expired COVID-19 Vaccine Moderna at PCN designated sites

Change history
  1. · Current content remains accurate
  2. · Current content remains accurate
  3. · Current content remains accurate
  4. · The name of the vaccine has changed to Spikevax®
  5. · Section 4.5 removal of outdated Foundry codes
    1. · Published

Dealing with spillages and breakages of COVID-19 vaccine Moderna at PCN designated sites

Change history
  1. · Current content remains accurate
  2. · Current content remains accurate
  3. · Current content remains accurate
  4. · The name of the vaccine has changed to Spikevax®
  5. · Section 6.3 removal of outdated Foundry codes
    1. · Published

Transporting COVID-19 Vaccine Moderna from PCN designated sites to end user locations

Change history
  1. · Section 4.3.4 amended to reflect advice in 4.3.6
  2. · Page content remains accurate
  3. · Section 4.3.5 amended to reflect revised content of Mutual Aid Policy V2
  4. · Appendix 1 updated to include individual vial in addition to carton selection for transport
  5. · Sections 4.3.4 - 4.3.7 amended to mirror information in other PCN Transport SOPs
    1. · Sections 4.3.4 and 4.3.5 amended following update of Mobile and Roving Models policy (October 2021)
    2. · Section 4.3.1 content amended to match other PCN transport SOPs
    3. · Section 5.0 added covering Mutual Aid Policy and transfer of COVID-19 vaccines including Moderna Spikevax
    4. · Section 4.3.1 aligned with Pharmacy Institutional Readiness for Management of Moderna Spikevax COVID-19 Vaccine V2 26/08/2021
    5. · Addition of information regarding movement between end user locations and link to NHSE position statement
    6. · Section 4.3.5 Addition of statement regarding immediate use
    7. · Section 4.3.4 Addition to include storage in suitably calibrated fridge at end user site
    8. · Section 4.3.2 Addition to clarify wholesaler responsibility regarding transit time greater than 6 hours to delivery
    9. · Confirmation that where term PCN designated site is used it covers any designated vaccination site
    10. · Data now available to support transportation of one or more thawed vials in liquid state for up to 12 hours at 2°C to 8°C (within the 30 days shelf life at 2°C to 8°C). SOP reinstated. Reference to use with vials received frozen removed
    11. · SOP suspended following confirmation that Moderna COVID-19 vaccine should not be used in mobile or roving settings if delivered in the thawed state
    12. · Published

Preparing COVID-19 Vaccine Moderna syringes for administration at end user locations

Change history
  1. · Current content remains accurate
  2. · Current content remains accurate
  3. · MVH8.1a updated to remove reference to diluted vial
  4. · MVH8 renamed as MVH 8a and updated to highlight this procedure is specific to the 0.5ml primary course dose. Added check that correct dose is being prepared and further advice to reduce risk of coring.
  5. · MVH8.1 renamed MVH 8.1a and updated to highlight this instruction is specific to the 0.5ml primary course dose. Added check that correct dose is being prepared and further advice to reduce the risk of coring.
    1. · MVH 8.3 updated to include both primary course and booster dose information
    2. · MVH 8b and MVH 8.1b uploaded as new documents specific to the 0.25ml booster dose
    3. · Data now available to support transportation of one or more thawed vials in liquid state for up to 12 hours at 2°C to 8°C (within the 30 days shelf life at 2°C to 8°C). SOP and supporting documents reinstated. Reference to use with vials received frozen removed
    4. · The name of the vaccine has changed to Spikevax®
    5. · MVH8 Section 5.3.17 Removal of outdated Foundry codes 6
    6. · SOP suspended following confirmation that Moderna COVID-19 vaccine should not be used in mobile or roving settings if delivered in the thawed state
    7. · Published

Other COVID-19 vaccines resources